Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Jan-Feb;66(1):11-5.
doi: 10.1016/j.ihj.2013.12.038.

A prospective study evaluating efficacy of polymer free Pronova XR stent in treatment of denovo coronary artery stenosis

N V Deshpande  1 , Parag Admane  2 , Mohan Deshpande  2 , H M Mardikar  3
Affiliations
Clinical Trial

A prospective study evaluating efficacy of polymer free Pronova XR stent in treatment of denovo coronary artery stenosis

N V Deshpande et al. Indian Heart J. 2014 Jan-Feb.

Abstract

Background: Drug eluting stents have remarkably improved results of percutaneous coronary angioplasty. Most of the currently available drug eluting stents uses a durable polymer as drug carrier which has been implicated in local inflammatory response and continued incidence of late and very late stent thrombosis. The Pronova XR stent is one from those new generation polymer free sirolimus eluting stents in which pharmaceutical excipient is used for the timed release of sirolimus from the XR stent platform instead of a polymeric coating.

Methodology: We consecutively recruited 121 patients undergoing elective or urgent PCI at our center. All the patients were followed up clinically and mandatory follow up angiogram at 6 months was done for one third of the total patients. An independent core lab analyzed paired angiograms.

Results: The primary efficacy endpoint was death, MI, TVR at 6 months which occurred in 6.66% patients. The QCA analysis showed reference vessel diameter of 2.5 + 0.44 mm at baseline and the minimal luminal diameter was 0.88 + 0.43 mm giving baseline diameter stenosis of 65.26 + 15.89%. The immediate post procedure in-segment diameter stenosis assessed was 23.68 + 8.96% which increased to 36.02 + 24.48% at follow up with a late lumen loss of 0.25 + 0.76 mm at mean of 191 days.

Conclusion: Coronary angioplasty with polymer free Pronova XR stents results in acceptable late lumen loss and very low target lesion revascularisation at short and intermediate term in unselected patients.

Keywords: Polymer free stent; Pronova XR; Sirolimus eluting stent.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Vessels treated.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Spaulding C., Daemen J., Boersma E., Cutlip D.E., Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare metal stents. N Engl J Med. 2007;356:989–997. - PubMed
    1. Feres F., Costa J.R., Jr., Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv. 2006;68:83–88. - PubMed
    1. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., BASKET-LATE Investigators Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584–2591. - PubMed
    1. Daemen J., Wenaweser P., Tsuchida K. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–678. - PubMed
    1. Abizaid A., Ribamar Costa J., Jr. New drug-eluting stents an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv. 2010;3:384–393. - PubMed

MeSH terms